NLVP
New Leaf Venture Partners Portfolio holdings
AUM
$52.9M
This Quarter Return
+18.59%
1 Year Return
-33.65%
3 Year Return
+15.24%
5 Year Return
+39.89%
10 Year Return
+615.06%
AUM
$97.3M
AUM Growth
+$97.3M
(+18%)
Cap. Flow
+$3.85M
Cap. Flow
% of AUM
3.95%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
10
New
–
Increased
2
Reduced
–
Closed
–
Top Buys
| 1 |
Arvinas
ARVN
|
$3.58M |
| 2 |
Iterum Therapeutics
ITRM
|
$270K |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Edgewise Therapeutics
EWTX
$1.51B
| $41.5M | 42.62% | 1,553,661 | – | – |
|
|
2
Arvinas
ARVN
$568M
| $35.3M | 36.32% | 1,434,721 +145,200 | +11% | +$3.58M |
|
3
Crinetics Pharmaceuticals
CRNX
$2.92B
| $7.21M | 7.41% | 141,000 | – | – |
|
4
Rallybio
RLYB
$22.4M
| $3.86M | 3.97% | 3,301,603 | – | – |
|
5
Rocket Pharmaceuticals
RCKT
$354M
| $2.78M | 2.86% | 150,706 | – | – |
|
6
Cogent Biosciences
COGT
$1.69B
| $2.71M | 2.78% | 250,765 | – | – |
|
7
Passage Bio
PASG
$22.7M
| $1.75M | 1.8% | 2,497,922 | – | – |
|
8
Alector
ALEC
$238M
| $1.58M | 1.63% | 339,569 | – | – |
|
|
9
Iterum Therapeutics
ITRM
$30.2M
| $376K | 0.39% | 345,020 +247,934 | +255% | +$270K |
|
10
X4 Pharmaceuticals
XFOR
$84.2M
| $224K | 0.23% | 335,000 | – | – |
|